[Progress on nuclear factor-E2 related factor 2 transcription factors in sepsis]

Area of Science:

• Biochemistry
• Molecular Biology
• Critical Care Medicine

Background:

• Sepsis, a life-threatening condition, is a major complication following trauma, burns, infections, and surgery.
• High incidence and mortality rates associated with sepsis, septic shock, and multiple organ dysfunction syndrome (MODS) necessitate effective therapeutic strategies.
• Nuclear factor-E2 related factor 2 (Nrf2) is a key transcription factor involved in the cellular antioxidant stress response.

Purpose of the Study:

• To review the alterations in Nrf2 expression and function during sepsis.
• To elucidate the regulatory mechanisms governing Nrf2 activity in the context of sepsis.
• To explore potential therapeutic interventions targeting Nrf2 for sepsis management.

Main Methods:

• Literature review of studies investigating Nrf2 in sepsis.
• Analysis of molecular pathways regulating Nrf2.
• Examination of experimental and clinical data on Nrf2 modulation in sepsis models.

Main Results:

• Nrf2 pathway is significantly altered in sepsis, impacting the expression of antioxidant and detoxification enzymes.
• Dysregulation of Nrf2 contributes to oxidative stress and organ damage in sepsis.
• Interventions aimed at modulating Nrf2 activity show promise in mitigating sepsis severity.

Conclusions:

• Nrf2 is a critical regulator of the cellular defense against sepsis-induced oxidative stress.
• Targeting the Nrf2 pathway represents a potential therapeutic avenue for improving sepsis outcomes.
• Further research is warranted to translate Nrf2-based strategies into clinical practice for sepsis treatment.